XML 17 R1.htm IDEA: XBRL DOCUMENT v3.26.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Apr. 02, 2026
Jun. 30, 2025
Document Type 10-K      
Amendment Flag false      
Document Annual Report true      
Document Transition Report false      
Document Period End Date Dec. 31, 2025      
Document Fiscal Period Focus FY      
Document Fiscal Year Focus 2025      
Current Fiscal Year End Date --12-31      
Entity File Number 001-41282      
Entity Registrant Name SUNSHINE BIOPHARMA INC.      
Entity Central Index Key 0001402328      
Entity Tax Identification Number 20-5566275      
Entity Incorporation, State or Country Code CO      
Entity Address, Address Line One 333 Las Olas Way      
Entity Address, Address Line Two CU4 Suite 433      
Entity Address, City or Town Fort Lauderdale      
Entity Address, State or Province FL      
Entity Address, Postal Zip Code 33301      
City Area Code 954      
Local Phone Number 330-0684      
Entity Well-known Seasoned Issuer No      
Entity Voluntary Filers No      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Small Business true      
Entity Emerging Growth Company false      
Entity Shell Company false      
Entity Public Float       $ 7,061,719
Entity Common Stock, Shares Outstanding     4,905,945  
ICFR Auditor Attestation Flag false      
Document Financial Statement Error Correction [Flag] false      
Auditor Name M&K CPAS, PLLC Bush & Associates CPA LLC    
Auditor Location The Woodlands, TX Henderson, Nevada    
Auditor Firm ID 2738 6797    
Common Stock [Member]        
Title of 12(b) Security Common Stock, par value $0.001      
Trading Symbol SBFM      
Security Exchange Name NASDAQ      
Warrant [Member]        
Title of 12(b) Security Warrants      
Trading Symbol SBFMW      
Security Exchange Name NASDAQ